Through the joint development of the Chinese Anti Epilepsy Association, the Neurotrauma Group of the Neurosurgery Branch of the Chinese Medical Association, the Brain Glioma Professional Committee of the Chinese Anti Cancer Association, the Neurooncology Professional Committee of the Chinese Neuroscience Association, and the Brain Trauma Group of the Trauma Surgery Branch of the Chinese Medical Association, the 2021 edition of the Chinese Guidelines for the Application of Anti epileptic Drugs in the Perioperative Period of Craniocerebral Surgery was jointly developed. The guidelines were published in the Journal of TherapeuticAdvancements in Neuro logical Disorders, providing strong evidence-based medicine for the treatment of postoperative epilepsy in neurosurgery related neurosurgery. On April 10, 2024, the Chengdu High tech Medical Association held an online seminar on the interpretation of the 2021 edition of the Chinese Guidelines for the Application of Anti epileptic Drugs in the Perioperative Period of Craniocerebral Surgery. More than 200 people participated online. This meeting will invite experts in the field of craniocerebral surgery and related fields to give lectures. The content covers a wide range of areas, has strong progressiveness, practicality and controllability, and is worth learning by grassroots doctors.